Edwards Lifesciences stock rallies and outperforms competitors
Updated
Updated · MarketWatch · Apr 30
Edwards Lifesciences stock rallies and outperforms competitors
13 articles · Updated · MarketWatch · Apr 30
Shares rose 2.81% to $83.50 on Thursday, with trading volume at 6.6 million, above the 50-day average of 5.0 million.
The gain ended a three-day losing streak and came as broader markets advanced, with the S&P 500 up 1.02% and the Dow Jones Industrial Average up 1.62%.
Edwards closed 4.99% below its 52-week high of $87.89; among peers, Abbott fell 0.59%, Medtronic rose 2.02%, and Stryker was unchanged.
Is Edwards' innovation pipeline strong enough to defend its premium valuation against faster-growing rivals?
As AI enters the operating room, who is responsible when the guidance algorithm gets it wrong?